NSECertificate under SEBI (Depositories and Participants) Regulations, 20182d ago · 12 Oct 2026, 01:06 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Emcure Pharmaceuticals Limited · EMCURE
✦ AI SummaryRegulatory
Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming no securities were received for dematerialization during the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
EMCURE_12102026130556_IntimationReg74_5_ofDPRegulation.pdf
View document text
Emcure
Ref: EPL/CS/SE/0089/2026 Date: October 12, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G, P J Towers,
Bandra Kurla Complex, Bandra (East), Dalal Street,
Mumbai – 400 051 Mumbai- 400 001
Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants)
Regulations, 2018, for the quarter ended September 30, 2026
Please find enclosed herewith a Confirmation Certificate under Regulation 74(5) of
the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30,
2026, received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent
(RTA) of the Company.
You are requested to take the same on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
Amruta Yangalwar
Company Secretary and Compliance Officer
ICSI Membership No: A25687
Encl.: As above
Emcure Pharmaceuticals Limited
Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India
Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060
E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Block No 202, 2nd Floor, Akshay Complex,
Off Dhole Patil Road, Pune - 411001
Tel : +91 20 26161629
Website: https://in.mpms.mufg.com
SEBI Registration no.: INR000004058
Date: October 12, 2026
Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2.
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune 411057 Maharashtra, India
Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and
Exchange Board of India (Depositories and Participants) Regulations, 2018.
Dear Sir/Madam,
With reference to the above-mentioned regulation, we hereby confirm that we did not receive
any securities for dematerialization during the quarter ended 30th September 2026.
We request you to kindly take note of the above in your records.
Thanking You,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly known as Link Intime India Private Limited)
Ashok Shetty
Vice President – Corporate Registry
Part of MUFG Pension & Market Services
C-101, Embassy 247, L. B. S. Marg, Vikhroli (West), Mumbai - 400 083. Tel. : +91 22 4918 6000.